Jump to page content
Titelblatt der Nationalen Strategie für gen- und zellbasierte Therapien mit Symbolen für acht Handlungsfelder, kreisförmig um ein zentrales Motiv angeordnet.
Titelblatt der Nationalen Strategie für gen- und zellbasierte Therapien mit Symbolen für acht Handlungsfelder, kreisförmig um ein zentrales Motiv angeordnet

National Strategy for Gene- and Cell-based Therapies

National Strategy

Gene and Cell-based Therapies, GCT are key areas for innovations in biomedical sciences and clinical care. They offer promising approaches for treatments of previously incurable diseases and can support regenerative processes. At the same time, there is still a great need for research to improve efficiency, safety and broader availability. Although Germany is leading in basic research and some technological developments, there are specific challenges regarding their implementation in medical care.

More
Bundesministerin Bettina Stark-Watzinger erhält von Professor Christopher Baum die Nationale Strategie für gen- und zellbasierte Therapien. Im Hintergrund stehen Mitglieder der Arbeitsgruppe für ein Gruppenfoto.

Gene and cell-based therapies

Gene and cell-based therapies (GCTs) are key technologies for innovations in biomedical research and healthcare. They not only modify the disease or alleviate symptoms, but also directly address the genetic cause of the disease process. This opens up promising prospects for patients with severe and very rare diseases for which there is currently no treatment available.

More

Topics

The National Strategy is being implemented in eight interactive topics for the development of gene- and cell-based therapies.

More

Moderation and working groups

In March 2023, the Federal Ministry of Education and Research (BMBF, which is now the Federal Ministry of Research, Technology and Space, BMFTR) commissioned the Berlin Institute of Health at Charité (BIH) to moderate the development process for the National Strategy. The BIH also provides the interim administration office for the National Strategy.

The measures of the National Strategy include:

   • creation and publication of the strategy document as well as initiation of the implementation of the measures proposed therein
   • the establishment and operation of the National Network Office for GCTs
   • the regulatory advice 
   • funding for projects and personnel 
   • the entrepreneurship program GeneNovate 
   • the GeneNovate Investors’ Day

The working groups discuss the various topics of the National Strategy GCT in detail, define the objectives of each topic and recommend specific measures for implementing the strategy.

More

People involved

Strategy Document